Edwards Lifesciences Shareholders Equity USD Trend

Edwards Lifesciences Corporation -- USA Stock  

USD 115.65  0.25  0.22%

This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Shareholders Equity USD of Edwards Lifesciences Corporation with missing and latest data points interpolated. Shareholders Equity in USD, converted by [FXUSD].
Shareholders Equity USD  10 Years Trend  
Slightly volatile
 Shareholders Equity USD 

Edwards Lifesciences Shareholders Equity USD Over Time

2015-12-31  2,503,100,000 
2016-12-31  2,619,000,000 
2017-12-31  2,695,842,105 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  1,584,128,509
Geometric Mean  1,407,321,528
Coefficient Of Variation  47.3
Mean Deviation  612,138,012
Median  1,479,300,000
Standard Deviation  749,328,650
Range  2,237,142,105
R Value  0.98
R Squared  0.95
Significance  0.00000005
Slope  202,979,591

Currently Trending

Purchased over 30 shares of
1 hour ago ago
Traded for 85.35
Purchased over 20 shares of
1 hour ago ago
Traded for 103.94
Purchased over 500 shares of
1 hour ago ago
Traded for 5.69